The three BRCA1 carriers (one each with breast, ovarian and pancreas cancer) all had tumors with truncating TP53 mutations which have previously been reported to serve as cooperative mutations in BRCA1-deficient germline cancers16 (Fig. 2B). This evidence concerns the gene BRCA1 and pancreatic neoplasm.